0
0
11/24/23 at 3:00am
Organization
Moneycontrol
Author
Moneycontrol News
33 words
0
Comments
According to analysts at HSBC, the USFDA's warning letter to Cipla hints at a lengthy resolution timeline and incremental costs
You are the first to view
https://www.moneycontrol.com/news/business/markets/cipla-may-extend-losses-on-usfda-warning-hsbc-cuts-target-price-11802451.html
Create an account
or login to join the discussion